Chronic hepatitis C virus (HCV) infection is a major cause of liver disease affecting 180 million people globally. HCV infection, both silent and slow in its revelation, and devastating in its...
A combined regimen of daclatasvir and sofosbuvir achieved sustained virologic response rates greater than 90% in an industry-sponsored trial involving patients with chronic HCV, according to study...
HOLLYWOOD, FLA. – Exposure to antibiotics other than penicillins, in particular metronidazole and quinolones, was associated with new-onset Crohn’s disease, based on a meta-analysis of observational...
The label of the hepatitis C antiviral drug telaprevir has been changed to include new dosing recommendations and contraindications, described in a "Dear Healthcare Professional" letter...
Many of the patients who seek our help in the midst of the cold and flu season seek what anybody suffering seeks: palliation. But perhaps it is the nature of our times and practice that we find...